RegulatoryOfficial
Infarmed allows English-labelled Teva UK dapagliflozin to ease Dalzior 10 mg supply shortage in Portugal
🇵🇹 INFARMED · Tue 17 Nov 2026
Portugal's regulator has exceptionally authorised UK-sourced dapagliflozin 10 mg packs with English labelling, carrying a Portuguese leaflet, to mitigate supply constraints affecting Dalzior 10 mg.
Infarmed, the Portuguese medicines authority, has authorised on an exceptional basis the use of a dapagliflozin medicine labelled in English. The measure, set out in information circular 106/CD/100.20.200 of 17 November 2026, is intended to mitigate supply constraints affecting Dalzior 10 mg film-coated tablets in packs of 28.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.
More Regulatory
All →
EEA Joint Committee extends three EU feed additive rules to Iceland and Norway
🇪🇺 EUR-Lex · Thu 19 Nov 2026
Health Canada lists Class II recall of Stryker's Blueprint shoulder-planning software over two bugs
🇨🇦 Health Canada · Wed 18 Nov 2026
FDA approves Infilbray, first treatment for neurological symptoms of Type 3 Gaucher disease
🇺🇸 FDA · Wed 18 Nov 2026
INFARMED lifts suspension of Limeciclina Atral 408 mg capsules after bioequivalence shown
🇵🇹 INFARMED · Wed 18 Nov 2026
Commission publishes minutes of SCHEER working group meeting on brain stimulators
🇪🇺 European Commission (DG SANTE) · Wed 18 Nov 2026
AIFA reminds sponsors how to pay Annual Safety Report evaluation fee
🇮🇹 AIFA · Wed 18 Nov 2026